Browse Discover Builder Rankings Pricing

Private market intelligence for investors, founders, and sales teams.

Product

Browse
Discover
List Builder
Rankings
Pricing

Developers

API Reference
API Keys

Company

About
Terms
Privacy
Contact

© 2026 Indexed.vc. All rights reserved.

Alterome Therapeutics: Company Profile & Funding | Indexed.vc

Alterome Therapeutics

Acquired

Home - Alterome

Precision Medicine

Headquarters: San Diego, California
Employees: 11–50
Business Model: B2B
Website: alterome.com

Total Funding: $231.0M
Last Round: $132.0M Series BApr 2024
Rounds: 3

About

Clinical-stage precision oncology company developing alteration-specific therapeutics for cancer treatment.

Tech & App Stack

Tech & App Stack is available on paid plans

Upgrade to Silver or higher to reveal the full technology and app stack for any company.

Sign up to view funding chart

Create a free account to see funding visualizations and detailed round data.

Create Free Account

Funding History

Series BSeries BApr 2024

Apr 2024

Extension Round

Extension Round

Nov 2022

Nov 2022

Series ASeries AJan 2022

Jan 2022

Investors

Sign up to view investors

Create a free account to see which investors have funded this company.

Create Free Account

Similar Companies

Simtra BioPharma Solutions

Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...

Bloomington, United States1001–5000Biotech, Contract Manufacturing

Private Equity·$4.3B·Oct 2023

Isomorphic Labs

AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...

London, United Kingdom201–500Artificial Intelligence, Biotech

Venture Unknown·$3.2B·May 2026

Impossible Foods

Food technology company creating plant-based meat and dairy products that replicate the taste and...

Redwood City, United States501–1000Agtech, Biotech

Series G Plus·$2.4B·Nov 2021

Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.

Tianjin, China5001–10000Healthcare, Biotech

Private Equity·$2.3B·Feb 2020

South Korean biotech company and global leader in medical aesthetics, manufacturing botulinum tox...

Chuncheon, South Korea201–500Aesthetics, Biotech

Private Equity·$2.3B·Aug 2021

Global full-service clinical research organization (CRO) and scientific advisory partner for biot...

Sydney, Australia1001–5000Biotech, Healthcare

Growth Equity·$1.9B·Mar 2025